Pharmaceutical

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: Likelihood of Approval

JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently in the Phase I in clinical pathway.

Aug 10, 2023 - 20:00
JY-302 is under clinical development by Jin Yang Pharmaceutical and is currently in the Phase I in clinical pathway.
Read the original article

Tags:

Previous Article

STAT+: Beleaguered drug manufacturer Emergent cuts jobs, executive role in busin...

Next Article

KKM-191-D by Genuone Science for Type 2 Diabetes: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CMN-005 by CoImmune for Nodal Marginal Zone B-Cell Lymp...

Sep 10, 2024

People with congenital heart disease are living longer — but facing new threat of heart failure

People with congenital heart disease are living longer ...

Dec 1, 2023

STAT+: FDA’s Janet Woodcock to retire early next year

STAT+: FDA’s Janet Woodcock to retire early next year

Nov 17, 2023